Does Fridays Have Retatrutide? No — Here's Every Medication They Actually Carry

Disclosure: This page has affiliate links to Fridays and Ro. If you start a program through one, we may earn a commission. It costs you nothing extra, and it did not change the answer — which is in the first sentence below, before any link on this page. Medical note: This page is for education. It does not diagnose or prescribe. A licensed clinician must decide what is safe and appropriate for you.

No. Fridays does not publicly offer retatrutide. We checked its homepage, pricing page, weight-loss menu, microdosing page, longevity page, testosterone page, Help Center, FAQ, blog, terms, and official social account on August 29, 2026. Across four public program menus, we counted 16 named product or form entries. Retatrutide is not one of them. It is still investigational, there is no FDA-approved retail product, and FDA says retatrutide cannot be used in compounding under federal law.

But there's a reason people keep asking this about Fridays specifically. We found it, and it's not what you'd guess.

Is this page for you?

Yes, if:

• You saw Fridays and retatrutide mentioned together and want a straight answer
• Someone offered you "compounded retatrutide" and you're checking if that's real
• You want to know what Fridays actually sells instead
• You want the verified ways to seek retatrutide before approval, without links to sketchy sellers

No, if:

• You want retatrutide dosing, mixing, or injection instructions — we don't publish those
• You want a list of places selling it — we don't link to those either
• You want the full trial results and side-effect data → Retatrutide availability in 2026

The short version, in one table

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Does Fridays have retatrutide? The disappointing answer

We're not going to bury this.

Fridays does not have a public retatrutide offer. Eli Lilly has not filed its U.S. application yet. Lilly says it plans to file a Biologics License Application in the first quarter of 2027. There is no FDA approval date and no retail launch date.

If a triple-hormone drug is the only thing you'll accept, no normal telehealth checkout can help you today. The two verified Lilly-run routes before approval are a clinical trial or single-patient expanded access, and we walk through both below.

But sit with this for a second, because it changes how you should read the answer.

Fridays says its compounded products come from partner pharmacies that use pharmaceutical-grade ingredients instead of research-grade material and submit independent testing. We did not inspect every license, test report, prescription, or batch record, so we treat those as provider-stated standards — not as facts we independently certified. Retatrutide still fails before any of those checks because FDA says it cannot be compounded under federal law.

When a company tells you "no," that isn't a smaller menu. That's the company showing you where its line is.

And the medicine Fridays does have that gets closest to what you wanted — tirzepatide — is the one with an FDA-approved brand version and published trial data behind it. Retatrutide's numbers are genuinely impressive. Lilly has now announced positive topline results from five phase 3 studies. Detailed peer-reviewed reports for some of the newest studies are still pending, and other phase 3 work continues.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. Use The RX Index's Find My GLP-1 Path tool to compare those routes before you choose. → Find My GLP-1 Path

What medications does Fridays actually offer?

Fridays publicly lists 16 product or form entries across four programs: weight loss, microdosing, longevity, and testosterone. That is not 16 unique active ingredients, and not all 16 are weight-loss drugs. The weight-loss pricing page lists compounded semaglutide and compounded tirzepatide injections, plus Ozempic, Zepbound, Wegovy Pill, and Wegovy Pen. Retatrutide does not appear on any of the four program menus.

We didn't rely on one menu or a search snippet. We opened the public program pages and counted what Fridays placed on each menu. Here's the whole list.

A help article can mention a medicine without proving that it is open to new patients. We did not count help-document mentions as public program offers. That is why this is a 16-entry menu audit, not a scrape of every drug name that appears anywhere on the domain.

Two more things we noticed, both easy to check yourself:

• Fridays publishes five clinical whitepapers in its footer — on NAD+, semaglutide, sermorelin, testosterone, and tirzepatide. There is no retatrutide whitepaper.
• We found no retatrutide article in the Fridays blog.

Check it yourself in 60 seconds. Open the Fridays pricing page, press Ctrl+F or Cmd+F, and type "retatrutide." Then repeat that check on its microdosing, longevity, and testosterone pages. A menu can change, so this is worth rechecking before you pay.

So why does everyone think Fridays has it?

Here's the part nobody else has connected.

The official Fridays Instagram account has posted content about retatrutide. That reel can appear when people search the two names together, which makes it look like an announcement.

It isn't one.

A company talking about a drug is not the same as a company selling it. Fridays has an active social account that covers GLP-1 news. It's not a product page, it's not a prescription pathway, and it's not a checkout.

If that post is what brought you here, you didn't imagine the connection. You just found the seam between "discussing" and "offering" — which is exactly the seam that costs people money in this category.

Why we say "does not publicly offer" instead of "will never offer"

We want to be precise, because precision is the only thing that makes a page like this worth trusting.

What we checked is Fridays' public pages. We are not Fridays patients. We didn't log into a private account, and we can't see unpublished plans. A company can change its menu.

What we can tell you is this: as of August 29, 2026, there is no public retatrutide offer from Fridays, and there is no legal path for Fridays to add it as a compounded product today. Those are two different facts, and both point the same direction.

Provider-stated versus independently verified

### That's the answer. Here's your next move. If compounded tirzepatide or semaglutide is what you're actually after, Fridays' short eligibility screen starts the clinical review and shows the current offer. A licensed clinician still decides whether any medication is appropriate. → See current Fridays pricing and start the eligibility screen (sponsored; prescription not guaranteed)

Why can't Fridays — or any pharmacy — compound retatrutide?

Retatrutide is investigational. It has no FDA approval, no approved label, and no lawful retail product. FDA states plainly that retatrutide cannot be used in compounding under federal law.

This is the question we get most from Fridays members, and it's a fair one: if they offer compounded semaglutide, why not this?

Because the two situations aren't close. Here's the actual mechanism.

Compounding means a licensed pharmacy prepares a medication for a patient instead of a drugmaker mass-manufacturing an FDA-approved product. Pharmacies cannot do that with just any molecule. The drug and the fill must meet federal and state rules.

(503A and 503B are sections of federal law. A 503A pharmacy compounds for an identified patient from a valid prescription. A 503B outsourcing facility follows a different federal framework. Neither label turns an otherwise barred retatrutide product into a lawful compound.)

An approved version is one gate that retatrutide fails. But approval is not a blank check for semaglutide or tirzepatide either. After their national shortages ended, pharmacies could no longer rely on the shortage rules to make routine copies. FDA says an essentially identical 503A product generally needs a prescriber to document a change that creates a significant difference for an identified patient. A prescription alone — or a lower price alone — does not settle that question.

That distinction matters because Fridays publicly markets compounded semaglutide and tirzepatide. Its public pages do not show the prescription, formula, pharmacy record, or legal basis for each individual fill. So we report two separate facts: Fridays offers the programs, and each actual compound still has to meet the law.

Here's the sentence that ends this whole debate:

Retatrutide has no approved product, was never on the shortage list, and cannot be used in compounding under federal law. That door was never open — not during the GLP-1 shortages, not now.

You'll find articles describing compounded retatrutide as a "shrinking" or "tightening" channel. That framing is wrong, and it's the most dangerous mistake in this entire topic. There was never a shortage of an approved retatrutide product because no approved product existed. So there was no shortage exception to shrink.

FDA has also warned telehealth companies, ingredient sellers, and outsourcing facilities over unapproved retatrutide activity. FDA's advice is not to buy prescription products from unsafe online sources, especially products sold as "research" material for people to use.

### So retail retatrutide is off the table right now. That makes the real question different. It's not which company has the newest drug. It's which lawful option fits your state, your insurance, your budget, and whether you want a needle. → Find My GLP-1 Path — compare your routes in about two minutes (free)

Someone offered you retatrutide. How do you check it?

If a website, clinic, or DM is selling retatrutide as a normal prescription, compounded injection, peptide, or "research" product for you to use, walk away. A clinical trial and physician-led expanded access do not look like a retail checkout.

Fridays' own published sourcing rules make a useful screen. Just keep the labels straight: these are standards Fridays says it uses for its products. We verified the statements, not every pharmacy file or batch.

One small precision note, because we'd rather be accurate than smooth: Fridays describes its pharmacies as "503A-accredited." That is not a complete credential by itself. 503A is a section of federal law. State licensure and any separate accreditation are different things. Ask for the pharmacy's legal name, address, and state license so you can verify the actual dispenser.

The three questions to send any seller

Copy these. Paste them. Watch what comes back.

1. "Which licensed pharmacy dispenses this? Give me its legal name, street address, and state license number."
2. "Is this labeled and dispensed for human use, or is it sold as research material?"
3. "Which licensed clinician reviewed my medical history, and under what trial or expanded-access authorization would I receive retatrutide?"

For retatrutide, a vague answer is not the only red flag. A polished answer does not fix the core problem either. A normal sale outside a clinical trial or authorized expanded-access process is not an authorized Lilly treatment route.

Retatrutide offer checker

If you already bought some

No affiliate links in this section. Nothing to sell you here.

If you already have a vial and you're feeling uneasy about it, the useful move is to talk to a real clinician. Bring the vial, label, receipt, and packaging if you can. If you may have used it or feel unwell, call Poison Control at 1-800-222-1222 or use its free online tool. If someone collapses, has a seizure, has trouble breathing, or cannot be awakened, call 911 now.

You can also report a side effect or product problem through FDA MedWatch. If a site appears to be selling prescription medicine illegally, FDA's BeSafeRx page links to the reporting route.

We're not going to tell you what to do with something we've never seen. We're telling you who can.

Who can legally get real retatrutide right now?

Two verified Lilly-run doors exist before approval, and neither is a normal telehealth checkout. The first is an enrolling retatrutide clinical trial. The second is Lilly's single-patient expanded-access route. Your doctor has to start the expanded-access request, and meeting the posted criteria does not guarantee access.

The expanded-access record was marked available when we checked it on August 29, 2026. Availability still depends on location, product supply, the full medical review, and required regulatory steps.

The posted inclusion criteria — all five have to be met:

• Age 18 or older
• BMI of 35 or higher despite adherence to and tolerance of the highest available dose of chronic weight-management therapy
• Two or more serious or life-threatening obesity-related complications that are being treated with standard care
• Unable to enter an ongoing retatrutide or similar investigational trial because of the protocol or because no enrolling site is reasonably accessible
• All standard treatment choices, including bariatric surgery, discussed through shared decision-making

The record also excludes a person with a medical contraindication to retatrutide.

Meeting all five still doesn't guarantee access. Lilly decides. The physician handles the request and approvals.

→ See both paths in full, including what to bring your doctor

What is the closest legal alternative to retatrutide?

Retatrutide works on three hormone pathways at once — GIP, GLP-1, and glucagon. That's why it's called a triple agonist. The closest FDA-approved receptor match is tirzepatide, the drug in Zepbound, which acts on GIP and GLP-1. Fridays lists Zepbound and also markets compounded tirzepatide. Those are not the same regulatory product.

This is the table most people actually need. Find the row that describes why you wanted retatrutide, and read across.

Two things you need to know before you use those numbers.

One. Compounded medications are not FDA-approved. FDA has not reviewed them for safety, effectiveness, or quality. They are not the same regulatory product as Ozempic, Wegovy, Mounjaro, or Zepbound. FDA says a compounded drug might be appropriate when a patient's medical need cannot be met by an FDA-approved drug or the approved drug is not commercially available.

Two. Fridays' public pricing pages currently contradict each other. Its Help Center lists compounded tirzepatide at $359 monthly or $240 per month effective on a 12-month plan, and semaglutide at $249 monthly or $150 effective on a 12-month plan. Its main pricing page also shows promo prices, different annual-plan figures, and a live "$xxx" savings placeholder. One separate promotion describes the same $896 charge as a four-month subscription while the Help Center calls it a three-month plan. Confirm the total charge, number of shipments, renewal date, and price per month on the payment screen before you pay anything.

The honest downsides of going with Fridays

Short and flat, no spin:

• Compounded medications aren't FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality.
• You don't pick your pharmacy. Fridays says the dispensing pharmacy is predetermined by dose, location, and other factors, and it cannot change the pharmacy on request.
• Cancel at least 72 hours before your billing date or the subscription renews for another cycle.
• Most fees are non-refundable. Prescription medication generally cannot be returned or refunded once dispensed or shipped, except where law requires it; Fridays says damaged or wrong shipments are normally replaced instead.
• Fridays says its compounded pharmacy network serves the U.S. except Louisiana. Individual programs and prescriptions can still vary by state.
• The pricing conflict above is real. Verify the exact checkout total and commitment before you submit payment.

### If two-pathway tirzepatide at a posted monthly price is the trade you want The next step is simple: start the screen and let a licensed provider decide whether any option is appropriate for your situation. Check the total price and commitment before payment. → See current Fridays pricing and start the eligibility screen (sponsored; prescription not guaranteed) Not sure compounded is right for you? Compare all your treatment paths first →

Will Fridays get retatrutide later?

Not unless retatrutide first clears FDA review and reaches the market. Lilly says it plans to file its U.S. application in the first quarter of 2027. Nobody can give you a real approval or launch date yet.

Four things have to happen first, in this order:

1. Lilly submits the application to FDA
2. FDA reviews the evidence and manufacturing package
3. FDA decides whether to approve it and for which uses
4. Lilly launches an approved product and makes it available to prescribers

If retatrutide is approved, the normal telehealth path would be a prescription for the Lilly brand, the way telehealth companies prescribe approved brands today. Approval would not create a broad legal market for cheap compounded copies. Any future compounding would still have to meet the law in effect at that time.

Nobody can tell you when. Anyone giving you a firm approval date is guessing, and we're not going to add to that pile.

A word on waitlists. You'll find retatrutide waitlists run by clinics and startups. Joining one may get you an email from that company. It does not create a place in an FDA line, a Lilly supply line, a clinical trial, or expanded access. A provider also cannot prescribe the drug before there is a lawful route.

What if you want FDA-approved treatment and insurance help?

Some people search for retatrutide because they want a strong option with real approval, not because they only want that molecule. If that's you, tirzepatide in Zepbound is the closest FDA-approved receptor match. Ro offers FDA-approved GLP-1 care and has a free insurance checker for the Ozempic pen, Wegovy pen, and Zepbound pen.

Ro's structure is different from Fridays. You pay for membership, and the medicine is billed separately.

• Membership: $39 for the first month, then $74/month on a 12-month prepaid plan, $89/month on a 6-month plan, $99/month on a 3-month plan, or $149 month to month
• Medication: billed separately; cost depends on the drug, insurance, and any manufacturer terms
• Insurance help: membership includes an insurance concierge, and the free checker can show coverage for the Ozempic pen, Wegovy pen, and Zepbound pen
• Scope limit: Ro says the free checker does not currently cover Zepbound KwikPen, Foundayo pill, or Wegovy pill

The free coverage checker is not a prescription and does not submit a treatment request. It answers the question you need answered first: does my plan appear to cover one of these three pens?

### If an FDA-approved medicine with insurance help is what you actually wanted The coverage check is free. See the result before you decide whether to start paid care. → Check your GLP-1 insurance coverage free on Ro (sponsored)

What do Fridays members say about service?

We're only using service-experience reviews here — how the company treats people, how fast things ship, how billing works. We are not using weight-loss result quotes on this page, because this is a page about an investigational drug and compounded products, and results quotes sitting next to that could imply things nobody has proven about retatrutide.

One disclosure that matters: Fridays labels the testimonials on its own website as paid. That's stated on its pricing page. So we checked an independent review platform instead.

At the time of our check, Trustpilot showed Fridays at 4.2 out of 5 from 4,652 reviews. The distribution was 79% five-star and 9% one-star. Trustpilot also said Fridays invites customers to review, had replied to 100% of negative reviews, and usually replied within one week.

"Fridays hands down is the best telehealth company I’ve worked with." — Makayla Helms, Trustpilot, June 4, 2026

That quote tells you about one person's service experience. It does not prove that a drug works, that you will get the same service, or that compounded medication is FDA-approved.

And one correction that matters: a person can have real retatrutide experience inside a Lilly clinical trial or authorized expanded-access case. A consumer testimonial attached to a retail vial does not prove legal retail access. The route is what you have to verify.

How did we verify this?

We checked Fridays' public program, pricing, blog, FAQ, terms, and Help Center pages; the official Fridays social post that creates the name connection; FDA's current retatrutide and compounding guidance; Lilly's July 2026 development update and expanded-access policy; the public expanded-access record; current Ro pricing and coverage-checker pages; and Trustpilot's live Fridays profile.

Everything below is what we saw, what we concluded, and what we could not see.

What we directly verified:

• Retatrutide does not appear on the four public Fridays program menus checked August 29, 2026
• Those menus contain 16 named product or form entries, not 15 unique medicines
• Fridays' Help Center price table and the conflicts on its main pricing page
• FDA's current statement that retatrutide cannot be used in compounding under federal law
• FDA's current restrictions on routine semaglutide and tirzepatide copies after the shortages
• Lilly's plan to file in the first quarter of 2027 and its statement that retatrutide cannot legally be sold or marketed for human use
• The posted expanded-access criteria and physician-first request path
• Current Ro membership pricing and the exact drugs covered by its free insurance checker
• Trustpilot's rating, review count, distribution, and company-response data shown on the date checked

What Fridays states, but we did not independently certify:

• That every partner pharmacy submits independent testing meeting the stated standards
• That every dispensed GLP-1 compound uses the base form rather than a salt
• The license, accreditation, formula, test report, and legal basis tied to every individual patient's fill

What we concluded — our editorial judgment, not a quote from anyone:

• Fridays does not publicly offer retatrutide because it is absent from the public menus we checked and FDA bars it from compounding
• The official Fridays social post is the most likely reason the two names appear together in search
• A normal retail seller offering retatrutide is showing you a compliance problem, not a better menu

What we could not verify:

• Anything inside a private Fridays patient account
• Unpublished Fridays plans
• The exact checkout price, pharmacy, formula, and prescription decision for any future reader
• Whether each named brand is open to a new patient in every state on the day that person applies

What we did not do: we are not Fridays patients. We did not place an order and we have not held a vial. That is exactly why we separate public proof, provider statements, and our conclusions instead of blending them together.

Why we built this: an official provider mention can look identical to a product offer in search results. This page exists to show you the difference before you spend money or buy something unapproved.

We are not publishing an RX Index Score on this page. Our score rates providers on clinical legitimacy, care quality, transparency, access, and cost — and a single availability question isn't a full provider evaluation. The scored review lives at Fridays GLP-1 reviews.

Frequently asked questions

Does Fridays have retatrutide?

No. We checked Fridays' public weight-loss, microdosing, longevity, and testosterone menus on August 29, 2026 and found no retatrutide listing.

Can Fridays prescribe retatrutide off-label?

No. Off-label prescribing starts with an approved medicine used in a way that is not on its label. Retatrutide has no approved product and no label, so there is nothing to prescribe "off" of.

Can Fridays or any pharmacy compound retatrutide?

No. FDA says retatrutide cannot be used in compounding under federal law. It is not a component of an FDA-approved drug and has not been found safe and effective for any condition.

What GLP-1 medications does Fridays offer instead?

Its public weight-loss menu lists compounded semaglutide injection, compounded tirzepatide injection, Ozempic, Zepbound, Wegovy Pill, and Wegovy Pen. Its microdosing page separately lists weekly injectable tirzepatide and daily oral semaglutide products.

Are compounded semaglutide and tirzepatide automatically legal with a prescription?

No. A prescription is required under 503A, but it is not the only rule. FDA says pharmacies cannot regularly make essentially identical copies of available approved drugs. A narrow patient-specific product may qualify when all conditions are met, including a prescriber-documented significant difference where the copy rule applies.

Is retatrutide FDA-approved?

No. It is investigational. Lilly says it plans to file a U.S. application in the first quarter of 2027. Filing is not approval, and there is no confirmed approval or launch date.

Is "GLP-3" the same thing as retatrutide?

"GLP-3" is a nickname people use online, and it's not scientifically accurate. Retatrutide is a triple agonist that acts on GIP, GLP-1, and glucagon receptors.

Did the Fridays Instagram post mean they sell it?

No. The official Fridays account has posted content discussing retatrutide, but a social post is not a medication listing, prescription route, or checkout.

Can I buy retatrutide online?

There is no FDA-approved retail retatrutide product to buy. Do not treat a peptide or product labeled "research use only" or "not for human consumption" as medicine. The verified preapproval routes are an enrolling clinical trial or physician-led expanded access.

Can I join a retatrutide clinical trial?

Possibly, if an enrolling study has a site you can reach and you meet that study's protocol. Use ClinicalTrials.gov and confirm the site directly. Do not rely on a seller's claim that its vial is "trial grade."

Is Fridays available in every state?

Fridays says its compounded-pharmacy network serves the U.S. except Louisiana. Individual products, clinicians, and programs can still vary by state.

How much does Fridays cost?

Fridays' Help Center lists compounded semaglutide at $249 month to month or $1,800 paid upfront for 12 months, which works out to $150 per month. It lists compounded tirzepatide at $359 month to month or $2,880 upfront for 12 months, which works out to $240 per month. Verify the total at checkout because Fridays' public pricing pages currently conflict.

Where to go from here

You came here for one thing: a straight answer about whether Fridays has retatrutide. It doesn't have a public offer. There is no FDA-approved retail product, and FDA says it cannot be compounded.

That's frustrating. It's also the cheapest piece of information you'll get this month, because the alternative was finding out after you'd already paid someone.

The documented Lilly routes are narrow preapproval routes right now. That does not mean you have no treatment choices. It means your next choice should be between the lawful options that actually fit your health, state, insurance, budget, and preference.

Still not sure which GLP-1 path is right for you? Take our free matching quiz.

Sources

• U.S. Food and Drug Administration — FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, current as of June 15, 2026
• U.S. Food and Drug Administration — FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize, updated April 1, 2026
• U.S. Food and Drug Administration — Zepbound Prescribing Information, revised February 2026
• Novo Nordisk — Wegovy Prescribing Information, revised June 2026; and Ozempic Prescribing Information, revised May 2026
• Eli Lilly and Company — Retatrutide Successful in Two Additional Phase 3 Obesity Trials, July 23, 2026
• ClinicalTrials.gov — Pre-approval Expanded Access of Retatrutide, NCT07629401
• Eli Lilly and Company — Expanded Access Policy
• Fridays — Homepage, Pricing, FAQ, Microdosing, Longevity, and Testosterone, checked August 29, 2026
• Fridays Help Center — Current Compounded-Medication Plan Pricing, checked August 29, 2026
• Fridays — Compounded Tirzepatide Four-Month Promotion, checked August 29, 2026
• Fridays Help Center — Compounding Pharmacies, dated July 30, 2026
• Fridays — Program Terms and Conditions, checked August 29, 2026
• Fridays Instagram — Official retatrutide reel, checked August 29, 2026
• Ro — Weight-Loss Program Pricing and GLP-1 Insurance Coverage Checker, checked August 29, 2026
• Trustpilot — Fridays Health Reviews, checked August 29, 2026
• Poison Control — Free online and phone help
• U.S. Food and Drug Administration — MedWatch Safety Reporting and BeSafeRx